Cellectar Biosciences (FRA:NV4) Price-to-Operating-Cash-Flow : (As of May. 22, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Cellectar Biosciences Price-to-Operating-Cash-Flow?

As of today (2024-05-22), Cellectar Biosciences's share price is €2.94. Cellectar Biosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.29. Hence, Cellectar Biosciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Cellectar Biosciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:NV4's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.93
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Cellectar Biosciences's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-0.42. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.29.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 27.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 40.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 53.80% per year.

During the past 13 years, Cellectar Biosciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 66.50% per year. The lowest was 27.80% per year. And the median was 54.05% per year.

Cellectar Biosciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Cellectar Biosciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellectar Biosciences Price-to-Operating-Cash-Flow Chart

Cellectar Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Cellectar Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cellectar Biosciences's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Cellectar Biosciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cellectar Biosciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cellectar Biosciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cellectar Biosciences's Price-to-Operating-Cash-Flow falls into.

Cellectar Biosciences Price-to-Operating-Cash-Flow Calculation

Cellectar Biosciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	2.94	/	-2.289
	=

Cellectar Biosciences's Share Price of today is €2.94.
Cellectar Biosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.29.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Cellectar Biosciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cellectar Biosciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Cellectar Biosciences (FRA:NV4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellectar Biosciences Inc (FRA:NV4) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

CLRB:USA

Address

100 Campus Drive, Florham Park, NJ, USA, 07932

Website

https://www.cellectar.com

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and better safety as a result of fewer off-target effects. Its lead PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.

Cellectar Biosciences (FRA:NV4) Headlines

No Headlines